Disruption of Metabolic Pathways - Perspectives for the Treatment of Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|6|1|77-87

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.6, Iss.1, 2006-02, pp. : 77-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA Damage Response Pathways and Cell Cycle Checkpoints in Colorectal Cancer: Current Concepts and Future Perspectives for Targeted Treatment

By  

Current Cancer Drug Targets, Vol. 12, Iss. 4, 2012-04 ,pp. : 356-371

Bentham Science Publishers

Access to resources Recommend Favorite

Accessing Cancer Metabolic Pathways by the Use of Microarray Technology

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 790-805

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer

By Montero Alberto J.  

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1385-1396

Adis International

Access to resources Recommend Favorite

A by-product of glutathione production in cancer cells may cause disruption in bone metabolic processes

By Seidlitz Eric P.   Sharma Mohit K.   Singh Gurmit  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 3, 2010-03 ,pp. : 197-203

NRC Research Press

Access to resources Recommend Favorite

Role of Adiponectin in the Metabolic Syndrome: Current Perspectives on its Modulation as a Treatment Strategy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 32, 2013-10 ,pp. : 5755-5763

Bentham Science Publishers

Access to resources Recommend Favorite